According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are HK$2.75 Billion. In 2023 the company made an earning of HK$1.46 Billion, an increase over its 2022 earnings that were of HK$1.16 Billion. The earnings displayed on this page is the company's Pretax Income.